editorial | Q871232 |
scholarly article | Q13442814 |
P50 | author | Jean-Martin Beaulieu | Q30513917 |
James R. Woodgett | Q39182989 | ||
Oksana Kaidanovich-Beilin | Q58380619 | ||
P2093 | author name string | Richard Scott Jope | |
P2860 | cites work | Emerging roles of glycogen synthase kinase 3 in the treatment of brain tumors | Q21129333 |
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS | Q21129334 | ||
GSK-3: Functional Insights from Cell Biology and Animal Models | Q30472813 | ||
Glycogen synthase kinase-3 in the etiology and treatment of mood disorders | Q30474415 | ||
GSK-3 as a Target for Lithium-Induced Neuroprotection Against Excitotoxicity in Neuronal Cultures and Animal Models of Ischemic Stroke | Q35154467 | ||
GSK3 and Alzheimer's Disease: Facts and Fiction…. | Q35182282 | ||
Glycogen synthase kinase-3: a promising therapeutic target for fragile x syndrome | Q35492486 | ||
Beyond cAMP: The Regulation of Akt and GSK3 by Dopamine Receptors | Q35505900 | ||
Functions of GSK-3 Signaling in Development of the Nervous System. | Q35564819 | ||
A pivotal role of GSK-3 in synaptic plasticity. | Q35757839 | ||
AKT/GSK3 signaling pathway and schizophrenia | Q35832061 | ||
GSK-3β and memory formation | Q35904141 | ||
Modulation of GSK-3 as a Therapeutic Strategy on Tau Pathologies | Q37946881 | ||
Glycogen Synthase Kinase-3 is an Intermediate Modulator of Serotonin Neurotransmission | Q37949586 | ||
GSK-3 Mouse Models to Study Neuronal Apoptosis and Neurodegeneration | Q37959957 | ||
Role of GSK3 Signaling in Neuronal Morphogenesis | Q37963374 | ||
GSK-3 and Wnt Signaling in Neurogenesis and Bipolar Disorder | Q37982704 | ||
Regulation by glycogen synthase kinase-3 of inflammation and T cells in CNS diseases | Q38371329 | ||
GSK3 as a Sensor Determining Cell Fate in the Brain | Q40963450 | ||
Inhibition of GSK3 by lithium, from single molecules to signaling networks | Q41285005 | ||
Localization and developmental changes of tau protein kinase I/glycogen synthase kinase-3 beta in rat brain. | Q48103081 | ||
Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase | Q48406074 | ||
P304 | page(s) | 48 | |
P577 | publication date | 2012-04-09 | |
P1433 | published in | Frontiers in Molecular Neuroscience | Q27721913 |
P1476 | title | Neurological functions of the masterswitch protein kinase - gsk-3. | |
P478 | volume | 5 |
Q54384589 | Amelioration of diabetes-induced cognitive deficits by GSK-3β inhibition is attributed to modulation of neurotransmitters and neuroinflammation. |
Q48447516 | Andrographolide activates the canonical Wnt signalling pathway by a mechanism that implicates the non-ATP competitive inhibition of GSK-3β: autoregulation of GSK-3β in vivo |
Q26745506 | Antipsychotic-induced sensitization and tolerance: Behavioral characteristics, developmental impacts, and neurobiological mechanisms |
Q47859883 | Comprehensive behavioral study and proteomic analyses of CRMP2-deficient mice |
Q48247868 | Development of [18F]Maleimide-Based Glycogen Synthase Kinase-3β Ligands for Positron Emission Tomography Imaging. |
Q33943345 | GSK-3 signaling in developing cortical neurons is essential for radial migration and dendritic orientation. |
Q42364658 | Heat Stress Reduces Sperm Motility via Activation of Glycogen Synthase Kinase-3α and Inhibition of Mitochondrial Protein Import |
Q44273064 | Inositol hexakisphosphate kinase-1 regulates behavioral responses via GSK3 signaling pathways |
Q36898190 | Neurological characterization of mice deficient in GSK3α highlight pleiotropic physiological functions in cognition and pathological activity as Tau kinase |
Q38149943 | New insights into the role of glycogen synthase kinase-3 in Alzheimer's disease. |
Q39008696 | Pharmacophore-based screening and drug repurposing exemplified on glycogen synthase kinase-3 inhibitors. |
Q35711117 | Structural Plasticity of Dendritic Spines Requires GSK3α and GSK3β |
Q38101982 | Understanding the relationship between GSK-3 and Alzheimer's disease: a focus on how GSK-3 can modulate synaptic plasticity processes |
Search more.